- Home
- UCL vs LVTX Comparison
UCL vs LVTX Comparison
Compare UCL & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- LVTX
- Stock Information
- Founded
- UCL 2014
- LVTX 2016
- Country
- UCL Hong Kong
- LVTX Netherlands
- Employees
- UCL N/A
- LVTX N/A
- Industry
- UCL Telecommunications Equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- UCL Consumer Discretionary
- LVTX Health Care
- Exchange
- UCL Nasdaq
- LVTX Nasdaq
- Market Cap
- UCL 48.4M
- LVTX 43.9M
- IPO Year
- UCL 2020
- LVTX 2021
- Fundamental
- Price
- UCL $1.21
- LVTX $1.65
- Analyst Decision
- UCL
- LVTX Strong Buy
- Analyst Count
- UCL 0
- LVTX 2
- Target Price
- UCL N/A
- LVTX $6.00
- AVG Volume (30 Days)
- UCL 26.1K
- LVTX 33.9K
- Earning Date
- UCL 11-13-2024
- LVTX 11-14-2024
- Dividend Yield
- UCL N/A
- LVTX N/A
- EPS Growth
- UCL N/A
- LVTX N/A
- EPS
- UCL 0.12
- LVTX N/A
- Revenue
- UCL $86,076,000.00
- LVTX $7,398,000.00
- Revenue This Year
- UCL $11.23
- LVTX N/A
- Revenue Next Year
- UCL $27.52
- LVTX N/A
- P/E Ratio
- UCL $10.48
- LVTX N/A
- Revenue Growth
- UCL 10.63
- LVTX N/A
- 52 Week Low
- UCL $1.16
- LVTX $1.13
- 52 Week High
- UCL $2.96
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- UCL 40.43
- LVTX 46.15
- Support Level
- UCL $1.16
- LVTX $1.59
- Resistance Level
- UCL $1.29
- LVTX $1.75
- Average True Range (ATR)
- UCL 0.07
- LVTX 0.08
- MACD
- UCL -0.01
- LVTX 0.00
- Stochastic Oscillator
- UCL 18.52
- LVTX 41.18
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.